Gene · 4986
NIH grants2,952
NIH projects whose papers are about the gene, through NIH's grant-paper links.
41 to 60 of 2,952
Download this page as JSON| Project | Title | Its papers about the gene | Newest fiscal year |
|---|---|---|---|
| T32DA007209 | Human Behavioral Pharmacology of Substance Abuse | 4 | 2025 |
| T32MH020017 | Ph.D. Training in Neuroscience | 4 | 2025 |
| T32NS073548 | Training in Mechanisms and Clinical Presentation of Pain | 4 | 2025 |
| U01AA013510 | 6/8: INIA Stress and Chronic Alcohol Interactions: Stress and Ethanol Self Administration in Monkeys | 4 | 2025 |
| U01AA014095 | 1/8: INIA Stress and Chronic Alcohol Interactions: Role of Dynorphin/KOR and Oxytocin Systems in Stress-Enhanced Alcohol Drinking, Relapse, and Impaired Behavioral Flexibility | 4 | 2025 |
| U01AA016658 | 11/11 Connectome-based fingerprinting of alcohol drinking in mice: mechanisms and biomarkers | 4 | 2025 |
| ZIADA000434 | Neurobiology Of Relapse To Opiate and Psychostimulant Drugs | 4 | 2025 |
| ZIAMH002927 | Neurobiology and Target Validation of Novel Therapeutic Agents in Mood Disorders | 4 | 2025 |
| ZIAMH002970 | Unit of Neuromodulation and Synaptic Integration | 4 | 2025 |
| P30AI124414 | ERC Einstein-Rockefeller-CUNY Center for AIDS research | 3 | 2025 |
| P30CA060553 | The Robert H. Lurie Comprehensive Cancer Center | 3 | 2025 |
| R01AI164266 | AI-based platform for predicting emerging vaccine-escape variants and designing mutation-proof antibodies | 3 | 2025 |
| R01DA041931 | Effect of buprenorphine on monocytes in the context of neuroAids and opioid abuse | 3 | 2025 |
| R01DA048153 | The role of RGS12 in differential modulation of G protein versus beta-arrestin signaling downstream of the kappa opioid receptor | 3 | 2025 |
| R01DA054694 | Kappa Opioid Receptors and Phospho-Dopamine Transporters Drive Cocaine Reward | 3 | 2025 |
| R01DA057790 | Targeting the allosteric sodium site with novel probes for delta opioid receptor | 3 | 2025 |
| R01NS096705 | Comprehensive Phenotyping of Specific Populations of Spinal Neurons Processing Cutaneous Information Before and After Injury | 3 | 2025 |
| R24AA019431 | Monkey Alcohol Tissue Research Resource (MATRR) | 3 | 2025 |
| R35GM143061 | Structural Determinants of Kappa Opioid Receptor Signaling | 3 | 2025 |
| R37DA033396 | DISSECTING DYNORPHIN-KAPPA OPIOID MEDIATED REINSTATEMENT OF NICOTINE PREFERENCE | 3 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.1.0
Sources 11
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNone stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GeneNone named. Public domain as US government information
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4986/grants?page=3